| |
| |
|
| Insider
Information: |
Schleifer Leonard S |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
466,877 |
|
|
Indirect Shares
|
228,469 |
|
|
| Direct
Value |
$458,608,608 |
|
|
|
Indirect Value
|
$224,422,814 |
|
|
| Total
Shares |
695,346 |
|
|
| Total
Value |
$683,031,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-17 |
466,877 |
2024-05-17 |
228,469 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2023-12-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,155 |
387,270 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2023-12-11 |
4 |
D |
$844.09 |
$10,838,960 |
D/D |
(12,841) |
374,429 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-13 |
4 |
OE |
$399.66 |
$81,212,511 |
D/D |
203,204 |
577,633 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-13 |
4 |
D |
$976.79 |
$141,080,710 |
D/D |
(144,433) |
433,200 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-14 |
4 |
AS |
$979.16 |
$24,481,164 |
D/D |
(25,000) |
408,200 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-15 |
4 |
AS |
$979.05 |
$10,725,946 |
D/D |
(10,941) |
397,259 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-17 |
4 |
AS |
$979.22 |
$22,355,714 |
D/D |
(22,830) |
466,877 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2011-09-06 |
4 |
A |
$0.00 |
$0 |
I/I |
7,000 |
7,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2011-09-06 |
4 |
AS |
$63.01 |
$521,631 |
I/I |
(7,900) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2013-09-09 |
4 |
AS |
$275.04 |
$1,377,332 |
I/I |
(5,000) |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO & President |
• • – |
2013-09-09 |
4 |
A |
$0.00 |
$0 |
I/I |
5,000 |
5,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO and President |
• • • |
2009-10-27 |
4 |
OE |
$10.44 |
$330,019 |
D/D |
31,611 |
132,058 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO and President |
• • • |
2009-12-15 |
4 |
OE |
$8.77 |
$1,315,500 |
D/D |
150,000 |
282,058 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
CEO and President |
• • • |
2009-12-15 |
4 |
D |
$19.89 |
$2,054,498 |
D/D |
(103,293) |
178,765 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • – |
2003-09-17 |
4 |
OE |
$14.75 |
$1,843,750 |
D/D |
125,000 |
200,095 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • – |
2003-09-17 |
4 |
D |
$20.95 |
$2,118,862 |
D/D |
(101,139) |
98,956 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • – |
2004-01-04 |
4 |
D |
$15.01 |
$219,987 |
D/D |
(14,656) |
111,290 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • – |
2004-01-04 |
4 |
OE |
$8.15 |
$219,995 |
D/D |
26,990 |
125,946 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-03-06 |
4 |
AS |
$18.00 |
$12,600 |
D/D |
(700) |
122,066 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-03-07 |
4 |
AS |
$18.00 |
$7,218 |
D/D |
(401) |
121,665 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-09-13 |
4 |
AS |
$16.52 |
$232,921 |
D/D |
(14,100) |
94,758 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-09-13 |
4/A |
AS |
$16.50 |
$262,783 |
D/D |
(15,900) |
91,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-10-17 |
4 |
AS |
$18.00 |
$540,067 |
D/D |
(30,000) |
61,665 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-11-06 |
4 |
OE |
$8.63 |
$1,317,699 |
D/D |
150,000 |
194,679 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Chief Exec Officer & President |
• • • |
2006-11-06 |
4 |
D |
$22.25 |
$2,136,312 |
D/D |
(96,014) |
115,651 |
0 |
- |
|
89 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
